Supplier Type
- contract manufacturer
- custom synthesis
- Manufacturer
- Reagent
- Trader
Supplier Region
- Telangana(56)
- Mumbai(20)
- Punjab(6)
- AndhraPradesh(10)
- Maharashtra(159)
- New Delhi(13)
- Hyderabad(28)
- Kerela(1)
- Uttar Pradesh(4)
- Karnataka(16)
- Gujarat(102)
- Bangalore(3)
- Haryana(10)
- West Bengal(4)
- Ahmedabad(2)
- Tamil Nadu(11)
- Kolkata(3)
- Himachal Pradesh(2)
- Orissa(1)
- Madhya Pradesh(7)
- Uttarakhand(1)
- Andhra Pradesh(1)
- Pune(1)
- Rajasthan(4)
- NaviMumbai(2)
Purity
- Complies as per Monograph
- 99.70
- 99%
- 99 %
- 98+
- 98.60
- 98.10
- 98.00%
- 98%
- 96.30
- 96%
- 95%
- 95 %
- 92%
- 90%
- 90 % Above
- 0.99
- 0.98
Package
- 25mg
- 1000mg
- 50g
- 1010010 kg and 100 kg+
- 2550025kg and 500 kg
- 50MG
- 100MG
- 250MG
- 1GM
- 1g
- 5g
- 10g
- 25g
- 100g
- 250g
- 2500ml
- 5kg
- 2510025 kg 100 kg
- 500g
- 500ml
- 1kg
- 10kg
- 20KG
- 25kg
- 50kg
- 500kg
- 1MT
- 25125kg and 1 MT
- 100kg
- 1000kg
- 5 kg
- 50010500 mg and 1.0 gm
- 1 kg
- 10 kg
- 10mt
- 100500100mg or 500 mg
- 25Kgs
- 50Kgs
- 1001100mg and 1 g
- 1001100 kg and 1 MT
-
Clopidogrel
113665-84-2
-
Clopidogrel camphorsulfonate
120202-68-8
-
Clopidogrel Bisulfate
120202-66-6
-
(S)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate hydrochloride
120202-65-5
-
Hydroxypioglitazone
146062-44-4
-
Clopidogrel besylate
7744256-69-0
-
5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide
1252927-47-1
-
67M-2
407582-47-2
-
67M-4
407582-49-4
-
RIP2 kinase inhibitor 1
1423186-80-4
Pioglitazone metabolite MIV 146062-44-4
Clopidogrel bisulphate 120202-66-6
Clopidogrel bisulphate 120202-66-6
Clopidogrel bisulphate 120202-66-6
FEBUXOSTAT METABOLITE 67M-2 407582-47-2